Pfizer Inc
NYSE: PFE
$28.93
-$0.29 (-1.0%)
Closing Price on October 21, 2024
PFE Articles
Jon OggThe short interest data for the June 30 settlement date is out, and there were selectively an increasing number of shares short in our go-to list of defensive high-yield stocks that are not...
Published:
Wikimedia CommonsThe Merrill Lynch team updated their Alpha Surprise stocks list for July, and they added some top stocks on Wall Street. We screened the list for the most liquid names that had the...
Published:
thinkstockJuly 2, 2014: Markets opened mixed on Wednesday with the S&P 500 starting just barely in the red based on Tuesday’s close. None of the major indexes made a big move today, and crude...
Published:
Last Updated:
thinkstockJune 26, 2014: Markets opened lower for a fourth straight day on Thursday and spent much of the day trying to reach the break-even line. Claims for jobless benefits fell slightly last week,...
Published:
Last Updated:
thinkstockJune 25, 2014: Markets opened lower for a third straight day on Wednesday, but led by tech and healthcare stocks equities headed higher soon after the bell sounded. The disappointing GDP...
Published:
Last Updated:
The short interest data for the first two weeks of June show that short interest was higher in almost all our go-to list of defensive high-yield stocks that are not utilities.
Published:
A new research report from Merrill Lynch documents some top stocks that have underperformed the overall market, some to the point where there could potentially be a snap-back rally
Published:
thinkstockJune 23, 2014: Markets opened mixed on Monday with the tech-heavy Nasdaq Composite starting the day with a small gain before giving in to selling pressure in mid-morning. Volumes remain low...
Published:
Last Updated:
courtesy of Ford Motor CompanyTwo factors are about ready to collide, and if history is any guide, the outcome could be ugly, at least for the short term. Since 1960, there have been only three years...
Published:
ThinkstockThe short interest data for the final two weeks of May have been released, and the results are somewhat surprising when it comes to the top high-yield safe dividends we follow. Some of the...
Published:
Wikimedia CommonsWith a very toppy market, and more than one firm on Wall Street warning of a potential summer sell-off, we were very impressed with the stocks that populate the Jefferies Franchise...
Published:
Pfizer looks like it is out of the bid now for AstraZeneca. What looks increasingly obvious for a lackluster performance is that Pfizer may now simply be having an identity crisis.
Published:
ThinkstockEvery time the economy gets good again, and every time the stock market gets high again, waves of mergers and acquisitions begin taking place. The stock market’s bull run is now more than...
Published:
A new report from the global equity strategy team at Credit Suisse maintains that the best defensive sector now is large cap pharmaceuticals. Here are their top large cap pharmaceuticals to buy now.
Published:
Several things are taking place ahead of the end of May, and the number of pundits getting more worried about the markets seems to be on the rise. The problem is that there are just as many bullish...
Published:
Last Updated: